A new diagnostic tool called gene expression profiling can detect dangerous types of lymphomas such as DLBCL much faster than previous methods. This will enable doctors to timely identify high-risk patients who do not respond to standard treatments.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer